Thimble Point Acquisition Corp. (THMA) to Combine with Pear Therapeutics in $1.2Bn Deal

Thimble Point (NASDAQ:THMA) has entered into a definitive agreement to combine with digital treatment provider Pear Therapeutics at an enterprise value of $1.19 billion, or 9.58x its 2023E revenue. Pear provides three FDA-approved digital health apps helping patients recover from addiction, insomnia and other anxiety-related issues. The combined company is expected to trade on the
Read More